- Email: [email protected]
Recently in The Lancet
Recently in The Lancet
Analysis and Interpretation
Primary Research
Editorial
Articles
Seeing red about HIV The Lancet Volume 367 Number 9513 March 11–17, 2006
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus Binh An Diep, Steven R Gill, Richard F Chang, et al Volume 367 Number 9512 March 4–10, 2006
Can an influenza pandemic really be contained? The Lancet Volume 367 Number 9514 March 18–24, 2006
Comment Genome of an epidemic community-acquired MRSA Mark C Enright Volume 367 Number 9512 March 4–10, 2006 Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patients Steven G Deeks Volume 367 Number 9512 March 4–10, 2006 Registration problems for antiretrovirals in Africa Nathan Ford, Marta Darder Volume 367 Number 9513 March 11–17, 2006 Turning the tide against tuberculosis Alimuddin Zumla, Zoë Mullan Volume 367 Number 9514 March 18–24, 2006 Families help cure tuberculosis Paul Garner, Jimmy Volmink Volume 367 Number 9514 March 18–24, 2006
272
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study Roman Prymula, Pascal Peeters, Viktor Chrobok, et al Volume 367 Number 9512 March 4–10, 2006 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, ART Cohort Collaboration (ART-CC) groups Volume 367 Number 9513 March 11–17, 2006 Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial James N Newell, Sushil C Baral, Shanta B Pande, et al Volume 367 Number 9514 March 18–24, 2006 Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment Reda MR Ramzy, Maged El Setouhy, Hanan Helmy, et al Volume 367 Number 9515 March 25–31, 2006
Meloxicam to prevent rabies? David Sharp Volume 367 Number 9514 March 18–24, 2006
Review and Opinion
Elimination of transmission of lymphatic filariasis in Egypt David H Molyneux Volume 367 Number 9515 March 25–31, 2006
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment Elizabeth L Corbett, Barbara Marston, Gavin J Churchyard, et al Volume 367 Number 9514 March 18–24, 2006
Review
http://infection.thelancet.com Vol 6 May 2006
Analysis and Interpretation
Primary Research
Editorial
Articles
Seeing red about HIV The Lancet Volume 367 Number 9513 March 11–17, 2006
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus Binh An Diep, Steven R Gill, Richard F Chang, et al Volume 367 Number 9512 March 4–10, 2006
Can an influenza pandemic really be contained? The Lancet Volume 367 Number 9514 March 18–24, 2006
Comment Genome of an epidemic community-acquired MRSA Mark C Enright Volume 367 Number 9512 March 4–10, 2006 Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patients Steven G Deeks Volume 367 Number 9512 March 4–10, 2006 Registration problems for antiretrovirals in Africa Nathan Ford, Marta Darder Volume 367 Number 9513 March 11–17, 2006 Turning the tide against tuberculosis Alimuddin Zumla, Zoë Mullan Volume 367 Number 9514 March 18–24, 2006 Families help cure tuberculosis Paul Garner, Jimmy Volmink Volume 367 Number 9514 March 18–24, 2006
272
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study Roman Prymula, Pascal Peeters, Viktor Chrobok, et al Volume 367 Number 9512 March 4–10, 2006 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, ART Cohort Collaboration (ART-CC) groups Volume 367 Number 9513 March 11–17, 2006 Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial James N Newell, Sushil C Baral, Shanta B Pande, et al Volume 367 Number 9514 March 18–24, 2006 Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment Reda MR Ramzy, Maged El Setouhy, Hanan Helmy, et al Volume 367 Number 9515 March 25–31, 2006
Meloxicam to prevent rabies? David Sharp Volume 367 Number 9514 March 18–24, 2006
Review and Opinion
Elimination of transmission of lymphatic filariasis in Egypt David H Molyneux Volume 367 Number 9515 March 25–31, 2006
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment Elizabeth L Corbett, Barbara Marston, Gavin J Churchyard, et al Volume 367 Number 9514 March 18–24, 2006
Review
http://infection.thelancet.com Vol 6 May 2006